Antioxidant and anti-inflammatory effects of resveratrol in airway disease

Antioxidants and Redox Signaling

Volumn 13, Issue 10, 2010, Pages 1535-1548

  Wood, Lisa G ^a,b   Wark, Peter A B ^a,b   Garg, Manohar L ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLERGEN; BUDESONIDE; CIGARETTE SMOKE; CYTOKINE; DEXAMETHASONE; GLUTATHIONE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG MECHANISM; HERPES SIMPLEX; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLUENZA; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; HUMANS; INFLAMMATION; LUNG DISEASES, OBSTRUCTIVE; OXIDATIVE STRESS; STILBENES;

EID: 77957738693     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.3064     Document Type: Article

References (179)

1. Abboud RT, Ofulue AF, Sansores RH, and Muller NL. Relationship of alveolar macrophage plasminogen activator and elastase activities to lung function and CT evidence of emphysema. Chest 113: 1257-1263, 1998.
2. Abe MK, Kartha S, Karpova AY, Li J, Liu PT, Kuo WL, et al. Hydrogen peroxide activates extracellular signal-regulated kinase via protein kinase C, Raf-1, and MEK1. Am J Respir Cell Mol Biol 18: 562-569, 1998.
3. Adler KB, Holden-Stauffer WJ, and Repine JE. Oxygen metabolites stimulate release of high-molecular weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via arachidonic acid dependent mechanism. J Clin Invest 85: 75-85, 1990.
4. Aggarwal BB and Shisodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phyto-chemicals: reasoning for seasoning. Ann N Y Acad Sci 1030: 434-441, 2004.
5. Agudo A, Slimani N, Ocke MC, Naska A, Miller AB, Kroke A, et al. Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr 5: 1179-1196, 2002.
6. Anekonda TS. Resveratrol: a boon for treating Alzheimer's disease? Brain Res Rev 52: 316-326, 2006.
7. Antczak A, Montuschi P, Kharitonov SA, Gorski P, and Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 166: 301-306, 2002.
8. Ara C, Karabulut AB, Kirimlioglu H, Coban S, Ugras M, Kirimliglu V, et al. Protective effect of resveratrol against renal oxidative stress in cholestasis. Ren Fail 27: 435-440, 2005. (Pubitemid 40993694)
9. Bai SK, Lee SJ, Na HJ, Ha KS, Han JA, Lee H, et al. beta-Carotene inhibits inflammatory gene expression in lipo-polysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med 37: 323-334, 2005.
10. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3: e2264, 2008.
11. Barnes PJ. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 342-344; discussion, 4; 2000.
12. Bastianetto S, Dumont Y, Han Y, and Quirion R. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? CNS Neurosci Ther 15: 76-83, 2009.
13. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006.
14. Baur JA and Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506, 2006.
15. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, and Barnes PJ. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leuko-triene B4. Chest 123: 1240-1247, 2003.
16. Belguendouz L, Fremont L, and Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 53: 1347-1355, 1997.
17. Biagioli MC, Kaul P, Singh I, and Turner RB. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic Biol Med 26: 454-462, 1999.
18. Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, and Belvisi MG. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kB-independent mechanism. FASEB J 19: 840-841, 2005.
19. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutrition Rev 56: 317-333, 1998.
20. Bridges RB, Chow CK, and Rehm SR. Micronutrient status and immune function in smokers. Ann N Y Acad Sci 587: 218-231, 1990.
21. Brooks CL and Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9: 123-128, 2009.
22. Busse WW. Inflammation in asthma: the cornerstone of the disease and target of therapy. J Allergy Clin Immunol 102: S17-S22, 1998.
23. Butland BK, Strachan DP, and Anderson HR. Fresh fruit intake and asthma symptoms in young British adults: confounding or effect modification by smoking? Eur Resp J 13: 744-750, 1999.
24. Buyukozturk S, Gelincik AA, Genc S, Kocak H, Oner-iyidogan Y, Erden S, et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med 204: 209-213, 2004.
25. Calhoun WJ, Reed HE, Moest DR, and Stevens CA. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 145: 317-325, 1992.
26. Cao Z and Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 489: 39-48, 2004.
27. Carcamo JM, Pedraza A, Borquez-Ojeda O, and Golde DW. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 41: 12995-13002, 2002.
28. Carey I, Strachan D, and Cook D. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med 158: 728-733, 1998.
29. Chan WK and Delucchi AB. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci 67: 3103-3112, 2000.
30. Chatzi L, Apostolaki G, Bibakis I, Skypala I, Bibaki-Liakou V, Tzanakis N, et al. Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax 62: 677-683, 2007.
31. Chatzi L, Torrent M, Romieu I, Garcia-Esteban R, Ferrer C, Vioque J, et al. Diet, wheeze, and atopy in school children in Minorca, Spain. Pediatr Allergy Immunol 18: 480-485, 2007.
32. Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De Vito P, et al. Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J Biol Chem 272: 2700-2708, 1997.
33. Clement MV, Hirpara JL, Chawdhury SH, and Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent ap-optosis in human tumor cells. Blood 92: 996-1002, 1998.
34. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, and Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 1239-1245, 2000.
35. Csiszar A, Labinskyy N, Podlutsky A, Kaminski PM, Wolin MS, Zhang C, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 294: H2721-H2735, 2008.
36. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58: 942-946, 2003.
37. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 24-31, 2003.
38. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, and Das DK. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 42: 281-289, 2005.
39. Das S, Tosaki A, Bagchi D, Maulik N, and Das DK. Po-tentiation of a survival signal in the ischemic heart by re-sveratrol through p38 mitogen-activated protein kinase= mitogen-and stress-activated protein kinase 1=cAMP response element-binding protein signaling. J Pharmacol Exp Ther 317: 980-988, 2006.
40. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krie-ken JH, and Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 190: 619-626, 2000.
41. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 1951-1957, 1998.
42. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 813-816, 1996.
43. Di Francia M, Barbier D, Mege JL, and Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150: 1453-1455, 1994.
44. Di Stefano A, Turato G, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, et al. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med 153: 629-632, 1996.
45. Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, and Booth T. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res 67: 155-162, 2005.
46. Docherty JJ, Smith JS, Fu MM, Stoner T, and Booth T. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Res 61: 19-26, 2004.
47. Docherty JJ, Sweet TJ, Bailey E, Faith SA, and Booth T. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res 72: 171-177, 2006.
48. Doelman CJA, Leurs R, Oosterom WC, and Bast A. Mineral dust exposure and free radical-mediated lung damage. Exp Lung Res 16: 41-55, 1990.
49. Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287: L774-L783, 2004.
50. Douwes J, Gibson P, Pekkanen J, and Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57: 643-648, 2002.
51. El-Mowafy AM and White RE. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 451: 63-67, 1999.
52. Ellwood P, Asher MI, Bjorksten B, Burr M, Pearce N, Robertson CF, et al. Diet and asthma, allergic rhino-conjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. Eur Respir J 17: 436-443, 2001.
53. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, and Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201, 1996.
54. Frankel EN, Waterhouse AL, and Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104, 1993.
55. Garvin S, Ollinger K, and Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231: 113-122, 2006.
56. Gern JE. Rhinovirus respiratory infections and asthma. Am J Med 112(Suppl 6A): 19S-27S, 2002.
57. Gescher AJ. Resveratrol from red grapes: pedestrian poly-phenol or useful anticancer agent? Planta Med 74: 1651-1655, 2008.
58. Gilks CB, Price K, Wright JL, and Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 152: 269-278, 1998.
59. Grievink L, de Waart FG, Schouten EG, and Kok FJ. Serum carotenoids, alpha-tocopherol, and lung function among Dutch elderly. Am J Resp Crit Care Med 161: 790-795, 2000.
60. Grievink L, Smit H, Ocke M, van't Veer P, and Kromhout D. Dietary intake of antioxidant (pro)-vitamins respiratory symptoms and pulmonary function: the MORGAN study. Thorax 53: 166-171, 1998.
61. Guarente L and Picard F. Calorie restriction: the SIR2 connection. Cell 120: 473-482, 2005.
62. Hanazawa T, Kharitonov SA, and Barnes PJ. Increased ni-trotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 162: 1273-1276, 2000.
63. Harju T, Kaarteenaho-Wiik R, Soini Y, Sormunen R, and Kinnula VL. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am J Respir Crit Care Med 166: 754-759, 2002.
64. Henderson WR Jr, Lu J, Poole KM, Dietsch GN, and Chi EY. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. J Immunol 164: 3360-3367, 2000.
65. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, and Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 53: 668-672, 1998.
66. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196, 2003.
67. Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, and Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 352: 203-206, 2003.
68. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Bee-cher CW, et al. Cancer chemopreventive activity of resver-atrol, a natural product derived from grapes. Science 275: 218-220, 1997.
69. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Bee-cher CW, et al. Cancer chemopreventive activity of resver-atrol, a natural product derived from grapes. Science 275: 218-220, 1997.
70. Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, and Latruffe N. Transport of resveratrol, a cancer chemopre-ventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 68: 1113-1118, 2004.
71. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, and Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160: 1532-1539, 1999.
72. Jin F, Wu Q, Lu YF, Gong QH, and Shi JS. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600: 78-82, 2008.
73. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, and Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 89: 381-385, 2002.
74. Karadag F, Kirdar S, Karul AB, and Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 19: 104-108, 2008.
75. Katsumata U, Miura M, Ichinose M, Kimura K, Takahashi T, Inoue H, et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 141: 1158-1161, 1990.
76. Keatings VM, Collins PD, Scott DM, and Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153: 530-534, 1996.
77. Kelly FJ, Mudway I, Blomberg A, Frew A, and Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 354: 482-483, 1999.
78. Khanduja KL, Bhardwaj A, and Kaushik G. Resveratrol inhibits N-nitrosodiethylamine-induced ornithine dec-arboxylase and cyclooxygenase in mice. J Nutr Sci Vitaminol (Tokyo) 50: 61-65, 2004.
79. Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CM, et al. Lycopene suppresses the lipopolysaccharide-induced phe-notypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 113: 203-211, 2004.
80. Kim H, Liu X, Kobayashi T, Conner H, Kohyama T, Wen FQ, et al. Reversible cigarette smoke extract-induced DNA damage in human lung fibroblasts. Am J Respir Cell Mol Biol 31: 483-490, 2004.
81. Kim J, Sanders SP, Siekierski ES, Casolaro V, and Proud D. Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 165: 3384-3392, 2000.
82. Kimura Y and Okuda H. Resveratrol isolated from Poly-gonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849, 2001.
83. Kobayashi T, Hashimoto S, Imai K, Amemiya E, Yama-guchi M, Yachi A, et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 96: 110-115, 1994.
84. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, and Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L478-L488, 2008.
85. Kuo PL, Chiang LC, and Lin CC. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72: 23-34, 2002.
86. La Vecchia C, Decarli A, and Pagano R. Vegetable consumption and risk of chronic disease. Epidemiology 9: 208-210, 1998.
87. Lagouge M,ArgmannC, Gerhart-Hines Z, Meziane H,Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006.
88. Lee M, Kim S, Kwon OK, Oh SR, Lee HK, and Ahn K. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol 9: 418-424, 2009.
89. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, and Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106: 1614-1617, 2002.
90. Li HF, Chen SA, and Wu SN. Evidence for the stimulatory effect of resveratrol on Ca(2\+)-activated K\+ current in vascular endothelial cells. Cardiovasc Res 45: 1035-1045, 2000.
91. Manna SK, Mukhopadhyay A, and Aggarwal BB. Re-sveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519, 2000.
92. Mannino DM, Ford ES, and Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114: 758-762, 2003.
93. Markus MA and Morris BJ. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin In-terv Aging 3: 331-339, 2008.
94. Marques FZ, Markus MA, and Morris BJ. Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 41:2125-2128, 2009.
95. Martinez J and Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59: 865-870, 2000.
96. McCormick ML, Roeder TL, Railsback MA, and Britigan BE. Eosinophil peroxidase-dependent hydroxyl radical generation by human eosinophils. J Biol Chem 269: 27914-27919, 1994.
97. McCusker K and Hoidal J. Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters. Am Rev Respir Dis 141: 678-682, 1990.
98. Meng X, Maliakal P, Lu H, Lee MJ, and Yang CS. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 52: 935-942, 2004.
99. Mezzetti A, Lapenna D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 112: 91-99, 1995.
100. Miedema I, Feskens EJM, Heederik D, and Kromhout D. Dietary determinants of long-term incidence of chronic non-specific lung diseases: the Zutphen study. Am J Epidemiol 138: 37-45, 1993.
101. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, and Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 155: 1770-1776, 1997.
102. Mizutani K, Ikeda K, Kawai Y, and Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 28: 55-59, 2001.
103. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32: 981-987, 2007.
104. Monagas M, Gómez-Cordovés C, and Bartolomé B. Evolution of the phenolic content of red wines from Vitis vinifera L. during ageing in bottle. Food Chem 95: 405-412, 2006. (Pubitemid 41400217)
105. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Resp Crit Care Med 162: 1175, 2000.
106. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, and Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensation in asthma patients. Am J Resp Crit Care Med 160: 216-220, 1999.
107. Morrison D, Rahman I, Lannan S, and MacNee W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 159: 473-479, 1999.
108. Nicholson KG, Kent J, and Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 307: 982-986, 1993.
109. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56: 432-437, 2001. (Pubitemid 32521359)
110. Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gi-slason D, Jogi R, et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epi-demiological study. Thorax 60: 451-454, 2005.
111. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cycloox-ygenase 2 (COX-2). Cell 87: 803-809, 1996.
112. Ozarus R, Tahan V, Turkmen S, Talay F, Besirli K, Aydin S, et al. Changes in malondialdehyde levels in bronchoalveo-lar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 5: 289-292, 2000.
113. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, et al. Inhibition of influenza A virus replication by resveratrol. J Infect Dis 191: 1719-1729, 2005.
114. Papi A and Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 274: 9707-9720, 1999.
115. Papi A, Papadopoulos NG, Stanciu LA, Bellettato CM, Pi-namonti S, Degitz K, et al. Reducing agents inhibit rhino-virus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells. FASEB J 16: 1934-1936, 2002.
116. Paredi P, Kharitonov SA, and Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 162: 1450-1454, 2000.
117. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, and Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 369-373, 2000.
118. Pendurthi UR and Rao LV. Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells. Thromb Res 106: 243-248, 2002.
119. Pirola L and Frojdo S. Resveratrol: one molecule, many targets. Life 60: 323-332, 2008.
120. Piver B, Berthou F, Dreano Y, and Lucas D. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol Lett 125: 83-91, 2001.
121. Pratico D, Basili S, Vieri M, Cordova C, Violi F, and Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2a III, an index of oxidant stress. Am J Respir Crit Care Med 158: 1709-1714, 1998.
122. Pryor WA and Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686: 12-27; discussion, 8, 1993.
123. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Cal-verley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Resp Crit Care Med 176: 532-555, 2007.
124. Rahman I, Biswas SK, and Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72: 1439-1452, 2006. (Pubitemid 44666744)
125. Rahman I and MacNee W. Role of oxidants=antioxidants in smoking-induced lung diseases. Free Radic Biol Med 21: 669-681, 1996.
126. Rahman I, Morrison D, Donaldson K, and MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154: 1055-1060, 1996.
127. Rahman I, Skwarska E, and MacNee W. Attenuation of oxidant=antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52: 565-58, 1997.
128. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 490-495, 2002.
129. Rathel TR, Samtleben R, Vollmar AM, and Dirsch VM. Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J Hypertens 25: 541-549, 2007.
130. Rautalahti M, Virtamo J, Haukka J, Heinonen OP, Sundvall J, Albanes D, et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Resp Crit Care Med 156: 1447-1452, 1997. (Pubitemid 27505508)
131. Renaud S and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
132. Rhoden KJ and Barnes PJ. Effect of hydrogen peroxide on guinea-pig tracheal muscle in vitro: role of cyclo-oxygenase and airway epithelium. Br J Pharmacol 98: 325-330, 1989.
133. Schunemann HJ, Grant BJB, Freudenheim JL, Muti P, Browne RW, Drake JA, et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 163: 1246-1255, 2001.
134. Sethi S, Maloney J, Grove L, Wrona C, and Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 991-998, 2006.
135. Sevov M, Elfineh L, and Cavelier LB. Resveratrol regulates the expression of LXR-alpha in human macrophages. Bio-chem Biophys Res Commun 348: 1047-1054, 2006.
136. Shaheen SO, Sterne JAC, Thompson RL, Songhurst CE, Mar-getts BM, andBurney PGJ. Dietary antioxidants andasthma in adults. Am J Respir Crit Care Med 164: 1823-1828, 2001.
137. Shakibaei M, Harikumar KB, and Aggarwal BB. Resvera-trol addiction: to die or not to die. Mol Nutr Food Res 53: 115-128, 2009.
138. Shanmugasundaram KR, Kumar SS, and Rajajee S. Excessive free radical generation in the blood of children suffering from asthma. Clin Chim Acta 305: 107-114, 2001.
139. Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS, et al. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO=cyclic GMP. Br J Haematol 139: 475-485, 2007.
140. Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia=reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34: 810-817, 2003.
141. Signorelli P and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16: 449-466, 2005.
142. Simmons DL, Botting RM, and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437, 2004.
143. Simon AR, Rai U, Fanburg BL, and Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275: C1640-C1652, 1998.
144. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, and Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62: 211-218, 2007.
145. Simpson JL, Scott RJ, Boyle MJ, and Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11: 54-61, 2006.
146. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, and Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289: L85-L95, 2005.
147. Subauste MC, Jacoby DB, Richards SM, and Proud D. Infection of a human respiratory epithelial cell line with rhi-novirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96: 549-557, 1995.
148. Tadolini B, Juliano C, Piu L, Franconi F, and Cabrini L. Resveratrol inhibition of lipid peroxidation. Free Radic Res 33: 105-114, 2000.
149. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27: 908-912, 2006.
150. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, Beutel-spacher SC, et al. Inhibition of NF-kB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 174: 7633-7644, 2005.
151. Tate RM, van Benthuysen KM, Shasby DM, McMurtry IF, and Repine JE. Oxygen-radical-mediated permability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis 126: 802-806, 1982.
152. Traves SL, Culpitt SV, Russell RE, Barnes PJ, and Donnelly LE. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 57: 590-595, 2002.
153. Trela BC and Waterhouse AL. Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 44: 1253-1257, 1996.
154. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202, 2004.
155. Urpi-Sarda M, Jauregui O, Lamuela-Raventos RM, Jaeger W, Miksits M, Covas MI, et al. Uptake of diet resveratrol into the human low-density lipoprotein: identification and quantification of resveratrol metabolites by liquid chro-matography coupled with tandem mass spectrometry. Anal Chem 77: 3149-3155, 2005.
156. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Do-menici L, and Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a shortlived vertebrate. Curr Biol 16: 296-300, 2006.
157. Varraso R, Fung TT, Barr RG, Hu FB, Willett W, and Ca-margo CA, Jr. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr 86: 488-495, 2007. (Pubitemid 47256936)
158. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72: 2219-2233, 2003.
159. Vural H and Uzun K. Serum and red blood cell antioxidant status in patients with bronchial asthma. Can Respir J 7: 476-480, 2000.
160. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, and Walle UK. High absorption but very low bioavailability of oral re-sveratrol in humans. Drug Metab Dispos 32: 1377-1382, 2004.
161. Wang Y, Catana C, Yang Y, Roderick R, van and Breemen RB. An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50: 431-435, 2002.
162. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 84: 210-215, 2000.
163. Wenzel E, Soldo T, Erbersdobler H, and Somoza V. Bioac-tivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49: 482-494, 2005.
164. Wickens K, Barry D, Friezema A, Rhodius R, Bone N, Purdie G, et al. Fast foods: are they a risk factor for asthma? Allergy 60: 1537-1541, 2005.
165. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
166. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686-689, 2004.
167. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, and Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 35: 967-974, 2000.
168. Wood LG, Garg ML, Blake RJ, Garcia-Caraballo S, and Gibson PG. Airway and circulating levels of carotenoids in asthma and healthy controls. J Am Coll Nutr 24: 448-455, 2005.
169. Wood LG, Garg ML, Blake RJ, Simpson JL, and Gibson PG. Oxidized vitamin E and glutathione as markers of clinical status in asthma. Clin Nutr 27: 579-586, 2008.
170. Wood LG, Garg ML, Simpson JL, Mori TA, Croft KD, Wark PAB, et al. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 171: 426-430, 2005.
171. Wood LG, Gibson PG, and Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 21: 177-186, 2003.
172. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 26-33, 2005.
173. Wu W, Chen Y, and Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues: implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274: 25933-25944, 1999.
174. Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, et al. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 92: 993-999, 1998.
175. Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med 151:1354-1358, 1995.
176. York GK, Peirce TH, Schwartz LW, and Cross CE. Stimulation by cigarette smoke of glutathione peroxidase system enzyme activities in rat lung. Arch Environ Health 31: 286-290, 1976.
177. Yu H, Pan C, Zhao S, Wang Z, Zhang H, and Wu W. Resveratrol inhibits tumor necrosis factor-[alpha]-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 62: 366-372, 2008.
178. Yu L, Sun ZJ, Wu SL, and Pan CE. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 9: 2341-2343, 2003.
179. Zhu J, Yong W, Wu X, Yu Y, Ilv J, Liu C, et al. Antiinflammatory effect of resveratrol on TNF-a ±-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 369: 471-477, 2008.